Amgen Inc (NASDAQ:AMGN) shares were slightly lower in premarket trading despite posting better-than-expected quarterly profit ...

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that ...

Amgen Inc (AMGN) reports a 9% revenue increase and advances its diverse portfolio with significant sales growth across key ...

Fifteen of the biotechnology company’s products delivered at least double-digit sales growth in the second quarter.

Amgen reported total revenue of $9.2 billion, topping the consensus of $8.9 billion, and non-GAAP earnings of $6.02 per share ...

Amgen (NASDAQ:AMGN) is set to release its earnings on Tuesday, August 5, 2025. Historically, Amgen's stock has shown a ...

Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug ...

This was the stock's second consecutive day of gains.

This segment is sponsored by Amgen This week we celebrated NBC4’s 8th annual “Stuffing Day” which is the culmination of this ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.